| Word Search (Top 10 - by date) |
New Patents Expand Coverage for Imaging and Therapeutic Applications of Peregrine's Phospholipid-Targeting Technologies
Peregrine Pharmaceuticals
(September 07, 2010)
|
CytRx Initiates Phase 2 Clinical Trial with Bafetinib in Advanced Prostate Cancer
CytRx
(September 07, 2010)
|
Alethia Biotherapeutics Secures C$9.6 Million in Series A Financing to Fund Its Therapeutic Monoclonal Antibody Product Pipeline
Alethia Biotherapeutics
(September 07, 2010)
|
Celgene Officially Notified of ANDA Filing for REVLIMID(R)
Celgene
(September 03, 2010)
|
MorphoSys Initiates Program Against Drug-Resistant MRSA Infections
MorphoSys
(September 02, 2010)
|
Seattle Genetics Achieves Milestone under Antibody-Drug Conjugate Collaboration with Agensys, an Affiliate of Astellas
Seattle Genetics
(September 02, 2010)
|
Peregrine to Report First Quarter Fiscal Year 2011 Financial Results After Market on September 9, 2010
Peregrine Pharmaceuticals
(September 02, 2010)
|
Abbott Japan And Eisai Submit Application For Additional Indication Of Humira®, A Fully Human Anti-TNF Monoclonal Antibody, For The Treatment Of Juvenile Idiopathic Arthritis In Japan
Eisai
(August 30, 2010)
|
Immunomedics Announces Fiscal 2010 Results
Immunomedics
(August 26, 2010)
|
Interim Report 2010
Neuren Pharmaceuticals
(August 26, 2010)
|
|
|
|
|
EvaluatePharma® - the premier source for pharma and biotech analysis.
Expert integration of financial and product data across historic and forecast timeframes (1986 to 2016) delivers a vast array of analytics by product, company, therapy area, EphMRA ATC code, technology, patent status (expiry date/ number), deals (upfront/ milestones), license revenues (royalties/ co-promotion) and much more.
|
| Summary Product Name Information |
|
|
More Product Information for EvaluatePharma® subscribersSubscribers see:
- Sales (historic and forecast to 2016 where available) listed by the reporting company or companies, including royalty, license and JV revenue where applicable
- Details of all events impacting the product
- Detailed product information, including sales forecasts listed by the reporting company or companies, indications (approved and in trial)
|
Register to access more FREE content:
- 2009 Product Sales analysis
- Download analysis into Excel
- Search 2 yrs of company press releases
| Research Codes Synonyms |
|
|
| Product: |
Cancer antibodies |
|
|
|
|
|